When was Biofire Diagnostics founded?

Biofire Diagnostics was founded in 1990 and raised its 1st funding round 22 years after it was founded.

Where is Biofire Diagnostics located?

Biofire Diagnostics is headquartered in Salt Lake City, United States.

How many employees does Biofire Diagnostics have?

As of May 31, 2026, the latest employee count at Biofire Diagnostics is 606.

Is Biofire Diagnostics a funded company?

Biofire Diagnostics is a funded company, having raised a total of $84M across 7 funding rounds to date. The company's 1st funding round was a $***** PE round, raised on Sep 19, 2012.

When was the latest funding round of Biofire Diagnostics?

Biofire Diagnostics' latest funding was a $***** Series A round on Nov 07, 2022, with participation from 7 investors. Its primary sector is Genomics. In United States, the Genomics sector has seen $1.17B in funding in 2026 to date.

Where does Biofire Diagnostics rank among its competitors?

Biofire Diagnostics ranks 15th amongst 398 active competitors, of which 91 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Daye, which secured $576K in Nov, 2025.

Who are the top competitors of Biofire Diagnostics?

Biofire Diagnostics' top competitors include Adaptive Biotechnologies, MeMed and HaystackAnalytics. Among them, Daye secured the most recent funding round in November, 2025.

Biofire Diagnostics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of molecular diagnostic solutions for the detection of genetic conditions. The company is continuously focused on developing new assays for their proprietary FilmArray System, a multiplex PCR system. The product contains Respiratory panel (RP) tests, Blood Culture Identification (BCID) Panel tests, Gastrointestinal (GI) Panel tests, and Meningitis/Encephalitis (ME) Panel tests.

Website: www.biofiredx.com/
Social

Key Metrics

Founded Year

1990

Location

Salt Lake City, United States

Stage

Acquired

Total Funding

$84M in 7 rounds

Latest Funding Round

Series A, Nov 07, 2022, $*****

Investors

Founders Fund & 9 more

Ranked

15^th among 398 active competitors

Employee Count

606 as on May 31, 2026

Similar Companies

Adaptive Biotechnologies & 422 more

Exit Details

Acquired by Institut Merieux (Dec 24, 2021)

View Biofire Diagnostics' full profile

Biofire Diagnostics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Biofire Diagnostics, Inc. CIN: 820439851 , United States, Active	Dec 31, 1999	-	8 (As on Dec 31, 2016)	-

Biofire Diagnostics got acquired by Institut Merieux on Dec 24, 2021 at an acquisition amount of $*****.

Click here to take a look at Biofire Diagnostics's acquisition in detail

Biofire Diagnostics has raised a total funding of $84M over 7 rounds. Its first funding round was on Sep 19, 2012. Its latest funding round was a Series A round on Nov 07, 2022 for $*****. 7 investors participated in its latest round. Biofire Diagnostics has 10 institutional investors.

Here is the list of recent funding rounds of Biofire Diagnostics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 07, 2022	9318732	Series A	6874869	1387555	4867522	2452715
Mar 01, 2015	7581486	Grant (prize money)	9187058	8995078	6833525	HHS
Aug 01, 2014	4592542	Grant (prize money)	4587425	4821921	6051956	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Biofire Diagnostics's funding rounds and investors

The founders of Biofire Diagnostics is Carl Wittwer.

Here are the details of Biofire Diagnostics' key team members:

Carl Wittwer: Co - Founder & Board Chairman of Biofire Diagnostics.

View details of Biofire Diagnostics's Founder profiles and Board Members

Biofire Diagnostics' employee count trend

Biofire Diagnostics has 606 employees as of May 26. Here is Biofire Diagnostics's employee count trend over the years:

Employee count trend for Biofire Diagnostics

Uncover Biofire Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biofire Diagnostics include Adaptive Biotechnologies, MeMed and HaystackAnalytics. Here is the list of Top 10 competitors of Biofire Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Adaptive Biotechnologies 2009, Seattle (United States), Public	Provider of clinical diagnostics, and drug discovery for immune diseases	$419M	Viking Global Investors, Matrix & 21 others	77/100
2nd	MeMed 2009, Tirat Carmel (Israel), Series D	Provider of machine learning based diagnostic solutions for infectious diseases	$163M	La Maison Partners, Ping An & 23 others	69/100
3rd	HaystackAnalytics 2018, Mumbai (India), Seed	Provider of genomics technology for personalized clinical decisions	$17.3M	Sun Pharma, STRIVE & 31 others	67/100
4th	Daye 2018, London (United Kingdom), Series A	Manufacturer of period care products and provider of health tests	$19.2M	Salica Investments, Khosla Ventures & 24 others	60/100
5th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
6th	NeuMoDx 2012, Ann Arbor (United States), Acquired	Developer of a platform for low cost molecular testing	$66M	Arboretum Ventures, Wolverine Venture Fund ... & 3 others	58/100
7th	Oncimmune 2006, Cambridge (United States), Acquired	Immunodiagnostics company developing biomarker platforms for cancer and immune diseases	-	IPF Partners, Balderton Capital & 9 others	58/100
8th	Karius 2014, Redwood City (United States), Series C	Provider of diagnostics for identifying infectious diseases using microbial DNA	$315M	Khosla Ventures, Gilde Healthcare & 16 others	58/100
9th	Clear Labs 2014, Menlo Park (United States), Series D	Provider of food safety technologies for the identification of pathogens	$171M	Menlo Ventures, Google Ventures & 26 others	57/100
10th	Seegene Technologies 2000, Seoul (South Korea), Public	Provider of advanced molecular diagnostics solutions	-	IMM Investment, HHS & 3 others	57/100
15th	Biofire Diagnostics 1990, Salt Lake City (United States), Acquired	Provider of molecular diagnostic solutions for the detection of genetic conditions	$84M	Athyrium Capital Management, Founders Fund ... & 8 others	54/100